As Her Oral Contraceptive Needs Change, Her Source Doesn't Have To
Brevicon
Making Informed Choices
A Choice For Nursing Mothers
Watson Choices In Oral Contraceptives
Contact Us
Oral Contraceptives Home
 
Search Go
Physician Prescribing Information
Patient Prescribing Information  
- Appropriate for patients who need low-dose norethindrone (0.5 mg)
- Contains 35 mcg of ethinyl estradiol
- If you prescribe low-dose monophasics, you can choose Brevicon®

SAFETY INFORMATION
Women who use oral contraceptives (OCs) should be strongly advised not to smoke due to the increased risk of cardiovascular side effects. Serious risks reported with the use of OCs include blood clots, stroke, and heart attacks. OCs are contraindicated in women with thrombophlebitis, thromboembolic disorders, breast cancer, hepatic or estrogen-dependent neoplasia, cerebrovascular or coronary artery disease, jaundice, or undiagnosed genital bleeding. OCs do not protect against HIV infection (AIDS) or other sexually transmitted diseases.

Please see full Prescribing Information.

Watson Pharmaceuticals, Inc.
Site Last Updated: 2006-06-23
This site is intended for US residents only. Copyright © 2003 - 2010 Watson Pharma, Inc. All rights reserved.
Terms of Use
Legal/Copyright Disclaimer Privacy Policy